OTC · GTHP
Healthcare · Medical - Devices
$0.24
Down-$0.05 (-17.24%)
Updated Aug 15, 2026, 10:20 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
GTHP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning GTHP.
GTHP research
Company profile and research snapshot.
GUIDED THERAPEUTCS INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Jul 14, 2026
PEACHTREE CORNERS, Ga., July 14, 2026--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.
Benzinga · Jun 16, 2026
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today
businesswire.com · Nov 19, 2025
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo Medical Instruments Corporation (YMIC). YMIC is headquartered in Jiangsu province, China and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the agreement, YMIC will initially purchase $200,000 worth of LuViva devices and single-.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning GTHP.
No results
No recent SID articles mention GTHP.
